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ABSTRACT
Transgenic maize produced by the insertion of the Cry transgene into its genome became the second most cultivated crop
worldwide. Cry gene from Bacillus thuringiensis kurstaki expresses protein derivatives of crystalline endotoxins which confer
insect resistance onto the maize crop. Mandatory labeling of processed food containing or made by genetically modified
organisms is in force in many countries, so, it is very urgent to develop fast and practical methods for GMO identification,
for example, biosensors. In the absence of an available empirical structure of Cry1A(b)16 protein, a theoretical model was
effectively generated, in this work, by homology modeling and molecular dynamics simulations based on two available
homologous protein structures. Molecular dynamics simulations were carried out to refine the selected model, and an analy-
sis of its global structure was performed. The refined models of Cry1A(b)16 showed a standard fold and structural charac-
teristics similar to those seen in Bacillus thuringiensis Cry1A(a) insecticidal toxin and Bacillus thuringiensis serovar kurstaki
Cry1A(c) toxin. After in silico analysis of Cry1A(b)16, two immunoreactive candidate peptides were selected and specific
polyclonal antibodies were produced resulting in antibody–peptide interaction. Biosensing devices are expected to be devel-
oped for detection of the Cry1A(b) protein as a marker of transgenic maize in food.
Key words: Cry1A(b)16; Bacillus thuringiensis; homology modeling; molecular dynamics simulation.
INTRODUCTION
In the past decade, since the middle of the XX century,
agriculture underwent a remarkable revolution because of the
development, creation, and cultivation of genetically modified
organisms (GMO) by “intentional manipulation”,1,2 where
genetic material has been altered in such a way that does not
occur naturally or by natural recombination.3 Maize is the
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second most cultivated GMO crop, corresponding to
approximately 30% of the global cultivated biotechnologi-
cal area (179.7 million hectares) in 2015.4 In the European
Union (EU) and worldwide, maize has the highest number
of authorized GM events (142).3
The insertion of a foreign gene (cry) into the maize
genome from a gram-positive spore-forming bacterium,
Bacillus thuringiensis kurstaki, to express protein deriva-
tives of crystalline endotoxins (d-endotoxins) became the
first successful creation of a GMO maize crop that is resis-
tant to the European corn borer (Ostrinia nubilalis).5
d-Endotoxins act at the intestinal level, and after
ingestion, the alkaline environment of the intestine and
the presence of proteases promote a release of internal
peptides (of d-endotoxins) that bind to specific receptors
in the plasma membrane of the insect’s epithelium,
resulting in pore formation in the intestinal wall. This
process induces severe inflammation, which causes severe
illness in the insect and eventually its death.6,7
This effect coupled with the fact that Cry proteins are
considered innocuous to humans, animals, and plants,
and are completely biodegradable makes these proteins
an attractive choice for genetic improvement of crops to
provide protection from insect pests.7–12
GM maize lines with Bt11 and MON810 transgenic
events are, by far, the most widely cultivated crops, and
both express Cry1A(b).3 Because the expressed protein is
a toxin, several concerns have been raised regarding food
safety and environmental issues. Therefore, it is necessary
to have proper methods for toxin monitoring and for
the detection of GMO.
The conventional methods for identification of GMO
relies mostly on molecular biology methods, such as the
polymerase chain reaction (PCR) technique for amplifica-
tion and detection of the transgene sequence or on immu-
nochemical methods such as the enzyme-linked
immunosorbent assays (ELISA).13 Nevertheless, this kind
of methods require extensive sample preparation high
associated costs, are time consuming, and are not suitable
for in situ assays. Consequently, it is important to develop
techniques that allow fast, accurate, and easy identification
and detection of GMO, for example, biosensors.
The Cry toxins have been widely used in insect pest con-
trol studies, but the three-dimensional (3D) structure of
the Cry1A(b)16 protein is not still available in protein data-
bases. The knowledge of the 3D structure is very important
for better understanding of the structure–function relations
of the protein and the underlying mechanisms.
Cry proteins are mostly composed of three domains
with defined structure and specific functions: a seven-
helix-bundle domain (DI) containing an a-helical bun-
dle, which is certainly involved in membrane insertion
and pore formation; a three-antiparallel b-sheet domain
(DII) which forms a “Greek key” topology organized to
form a b-prism fold and contains surface-exposed loops
that are considered the most probable candidates for
receptor binding;5 and a b-sandwich domain (DIII) con-
sisting of two twisted antiparallel b-sheets, forming a b-
sandwich with a jelly roll topology.
Additionally, DIII is considered a multifunctional
domain that plays a fundamental role in the biochemis-
try, structural integrity, membrane penetration, ion chan-
nel function, and receptor binding.14
Some reported studies based on homology modeling
and molecular dynamics simulations have already been
conducted on other Cry proteins, with a previously pro-
posed structural model for protein Cry1A(b)16.14,15 On
the other hand, the structure–function research on this
protein has been based on its closest structural homologs,
Cry1A(a) and Cry1A(c), which represent a more probable
and realistic model than the model studied before.
The aim of the present study was to develop a new
approach to monitor GMO in processed foods. The
developed approach consists of prediction of a homology
modeling and molecular dynamics simulations of the 3D
structure of the Cry1A(b)16 protein in accordance with
bioinformatic data and extensive in silico analysis of
immunogenic peptides to obtain marker peptides that
can function as immunogens for production of novel
antibodies for biorecognition of Cry1A(b)16.
Two peptides of interest were selected on the basis of their
immunogenicity. The novel 3D structure of the target toxin
obtained by homology modeling and molecular dynamics
simulations is expected to not only form the basis for the
development of a protein-based biosensor but should also
facilitate the design of hybrid Cry proteins and new fusion
proteins with novel features against several species of insects,
thereby improving management of pests.5,16
MATERIAL ANDMETHODS
Selection of Cry1A sequences and 3D
structures
Cry1A(b)16 protein sequence, accession No. AAK55546,
was retrieved from the National Center for Biotechnology
Information database (NCBI, http://www.ncbi.nlm.nih.
gov), and homologous empirical 3D structures of
Cry1A(b)16 were explored at RCSB Protein Data Bank
(PDB) (http://www.rcsb.org/pdb/home/home.do).
Two homologue protein structures were chosen as
templates: Cry1A(a) from Bacillus thuringiensis (PDB ID:
1CIY; 2.25 A˚ resolution, 88% sequence identity, and 92%
of conserved residues) and Cry1A(c) from Bacillus thur-
ingiensis (PDB ID: 4ARY; 2.95 A˚ resolution, 83%
sequence identity, and 86% of conserved residues).
Homology modeling
By means of the 3D structures of Cry1A(a) and
Cry1A(c) that have already been empirically determined
by X-ray diffraction, structural models of Cry1A(b)16
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were generated by homology modeling in the MODEL-
LER 9v13 software.17,18 The model with the most nega-
tive value for the discrete optimized protein energy
(DOPE) function19 was chosen for an additional stage
of refinement using molecular dynamics simulations.
For verification and validation of protein structures
during and after model refinement, different software
packages were used, namely PROCHECK20 and
ERRAT21 from the Structure Analysis and Verification
Server (SAVES) and the Z-Score software (ProSA-web
Protein Structure Analysis) (Table I).22,23
Molecular dynamics simulations
Simulations were carried out using GROMOS96 53a6
force field24 implemented in the GROMACS package25,
version 4.5.5. All systems were simulated in the NPTensem-
ble (wherein the number of particles, pressure, and tempera-
ture were all constant) and periodic boundary conditions.
The dimensions of the central box were chosen in such a
way that the minimal distance of any protein atom to the
closest box wall was 12 A˚. The simulations were conducted
using explicit solvent water molecules described by the sim-
ple point charge (SPC) model.26 The total charge of the sys-
tems was 23 for homology modeled (HM)-Cry1A(b)16.
Sodium ions were added to neutralize each system.
Protein structure was subjected to a maximum of 500
steps of steepest-descent energy minimization. One pico-
second of a molecular dynamics simulation was per-
formed restraining the protein structure to relax strong
solvent–solvent and solvent–protein nonbonded interac-
tions. Initial velocities were assigned according to the
Maxwell distribution. The simulations were performed
for 30 ns using an integration time step of 2 fs.
Each system was heated with gradual increments at
the following temperatures: 100 K (10 ps), 150 K (5 ps),
200 K (5 ps), and 250 K (5 ps). The temperatures of the
systems were adjusted to 310 K. The first 15 ns of each
simulation was considered a part of the heating (0.025
ns) and equilibration (14.975 ns) steps; therefore, they
were not used for data analysis. The temperatures of the
solvent and solutes (protein and sodium ions) were inde-
pendently coupled to a thermal bath with relaxation time
of 0.1 ps by means of the Berendsen thermostat.26 The
pressure in the systems was weakly coupled to a pressure
bath of 1 atm with isotropic scaling and 0.5 ps relaxation
time using the Parrinello-Rahman barostat.27,28
Bond lengths were constrained by the LINCS algo-
rithm29 with fourth-order expansion. Electrostatic inter-
actions among nonligand atoms were evaluated by the
particle mesh Ewald (PME) method30 with charge grid
spacing of approximately 1.0 A˚. The charge grid was
interpolated on a cubic grid with the direct sum toler-
ance set. Lennard-Jones interactions were evaluated by
means of a 14 A˚ atom-based cutoff. The pair list was
updated every 10 steps.
Peptide synthesis and purification
Peptides were selected by in silico evaluation of the
Cry1A(b)16 protein (accession No. AAK55546; Fig. 1), on
the basis of their sequence and immunogenicity.31,32 The
parameters used in silico involved theoretical digestion at
trypsin and chymotrypsin cleavage sites, sequence and
structure determination of epitopes (B-Cell and T-cell epi-
tope prediction tools), cross-reactivity, and secondary-
structure prediction for the selected peptides.31–33
Final selection of the peptides for synthesis, purifica-
tion, and production of polyclonal antibodies was based
on the exposure of amino acid residues to the solvent in
the native protein.
The peptides were manually synthesized by means of a
solid-phase approach using Fmoc/t-butyl chemistry.34
Peptide elongation was carried out in polypropylene
syringes fitted with a polyethylene porous disk. Solvents
and soluble reagents were removed by suction. The rink
amide (4-Methylbenzhydrylamine hydrochloride) MBHA
resin was used for the synthesis of the peptides. A Cys
was incorporated at the C-terminus in order to couple
the peptides to a carrier protein prior to their inocula-
tion into animals. Samples were treated with the mixture
trifluoroacetic acid/triisopropylsilane/water (TFA/TIS/
H2O; 95:2.5:2.5, v/v/v) to remove the protective groups.
Peptide purification was carried out by means of an ana-
lytical reverse-phase high-performance liquid chromatog-
raphy (RP-HPLC) system (Shimadzu Prominence
Table I
Comparison of Quality of Templates Structures with the Homology Model
Template or model
Procheck
Errat Z-ScoreCorea Allow.b Gener.c Desall.d Overall G-factore
BthCry1A(a) (1CIY) 88.8% 10.6% 0.4% 0.2% 0.17 95.75 29.47
BthCry1A(c) (4ARY) 91.5% 8.3% 0.0% 0.2% 0.09 96.59 29.81
HM-Cry1A(b)16 93.2% 6.2% 0.4% 0.2% 0.02 90.73 29.78
aPercentage of residues in most favored regions.
bPercentage of residues in permitted areas.
cPercentage of residues in regions generously allowed.
dPercentage of residues in areas not permitted.
edihedral G-factor [37].
Instrument, Shimadzu, Kyoto, Japan) on a Phenomenex
RP chromatography column (Phenomenex columns
Kinetex, 5 mm C18 503 21.20 mm). Each peptide was dis-
solved in the mixture H2O:CH3CN (6:4, v/v) and loaded
into the RP-HPLC system using a gradient of CH3CN,
starting with 0.1% trifluoroacetic acid in water and then
increasing CH3CN concentration to 100% during 60 min
at a flow rate of 1.0 mL/min. Peptides were monitored
at 216 and 280 nm. The formula (A215 – A225) 3 144
(mg/mL) was applied to peptide quantification.35
Determination of purity and molecular masses of the
synthetic peptides was performed by matrix-assisted
laser desorption ionization tandem time-of-flight
(MALDI-TOF/TOF) mass spectrometry (MS,
ultrafleXtremeTM, Bruker Daltonics, Bremen, Germany).
The instrument was operated in positive ion mode and
controlled by the Compass for Flex software, version 1.3
(FlexControl 3.3, FlexAnalysis 3.3, Bruker Daltonics,
Bremen, Germany); 5000 laser shots were accumulated
per spectrum in the MS and MS/MS modes.
One-microliter aliquots of the chromatographic fractions
dissolved in an a-cyano-4-hydroxycinnamic acid matrix
solution (1:3, v/v) were applied to a stainless steel plate and
dried at room temperature for 30 min. The peptide monoi-
sotopic mass was determined in reflector mode with exter-
nal calibration, using the peptide calibration standard for
Figure 1
(A) Schematic representations of the HM-Cry1A(b)16 model. Domain I is red, domain II is blue, and domain III is yellow. (A) Ribbon trace. (B)
Molecular surface. The image was generated using UCSF Chimera (https://www.cgl.ucsf.edu/chimera/).37 (B) Time dependence of the structural
parameters from molecular dynamics simulations with respect to the initial structure. (C) Atom-positional root mean-square deviation (RMSD) of
Ca atoms; (D) radius of gyration (Rg); (E) the total number of hydrogen bonds (Nhb); (F) total solvent-accessible surface area (SASA). Color leg-
end: Cry1A(b)16_S01 (black) and Cry1A(b)16_S02 (red). The image was generated using Xmgrace (http://plasma-gate.weizmann.ac.il/Grace/).38.
an MS mixture (mass range up to 4000 Da, Bruker Dalton-
ics). Peptides were loaded onto an automatic sequencer for
De novo sequencing in “LIFTTM” technology mode.
Antibody production and immunoreactivity
The specific antibodies were produced by a specialized
biotech company (GenScript, NJ, USA). Briefly, synthetic
peptides PcH77-91 and Pt282-292 were coupled to a car-
rier protein called keyhole limpet hemocyanin (KLH)
(for immunization) using a single-step coupling proto-
col.36 Peptide conjugation to KLH via the C-terminal
Cys residue was carried out using m-maleimidobenzoic
acid N-hydroxysuccinimide ester (MBS)-activated KLH
(Pierce Chemical Company, Rockford, Illinois, USA). For
each peptide, rats were immunized according to standard
procedures.36
Immune responses were screened using a dot blot
assay as follows: peptides coupled to KLH as well as
carrier-only controls (all at 20 mg/mL in 0.2 M phos-
phate buffer pH 7.4), were incubated with nitrocellulose
membrane strips for 2 h at 378C. The following steps
were performed at room temperature. After blockage in
10% fetal calf serum (FCS) in D-MEM (Dulbecco’s Mod-
ified Eagle’s Medium) for 2 h, 2 mL aliquots of serially
diluted serum samples were spotted onto antigen-coated
membranes, incubated for 2 h, washed 33 in 0.01M
phosphate buffer pH 7.4, incubated with horseradish
peroxidase-conjugated goat anti-rat IgG antibodies
(Sigma-Aldrich, cat. # A9037) diluted 1:100 with DMEM
plus 10% FCS, washed 33 for 5 min in PBS, and devel-
oped using 1,4-chloronaphthol. To remove polyclonal
antibodies against the KLH carrier, selected antisera were
affinity-purified on a column with a KLH-conjugated
resin (Hena s.r.o., Czech Republic).
RESULTS AND DISCUSSION
Homology modeling
Three-dimensional information on Cry1A(b)16 was
obtained by homology modeling; for this purpose, two
proteins homologous to Cry1A(b)16 (NCBI accession
No. AAK55546.1) with available empirical 3D structures
in the PDB were used as model templates: Cry1A(a)
from Bacillus thuringiensis (PDB ID 1CIY) and Cry1A(c)
from Bacillus thuringiensis (PDB ID 4ARY). From the
primary sequence of 1155 aa, a structural model of the
Cry1A(b)16 core protein, designated as HM-Cry1A(b)16,
Table III
Average Structural Parameters of HM-Cry1A(b)16 from the Last 5 ns of
the Simulations
HM-Cry1A(b)16 RMSD (nm)a Rg (nm3)b NHb-intrac SASA (nm2)d
Simulation 01 0.296 0.01 2.576 0.006 475.36 10.0 133.86 2.2
Simulation 02 0.276 0.01 2.566 0.008 471.16 10.3 134.76 2.7
aRoot mean square deviation of HM-Cry1A(b)16 Ca atoms from starting coordi-
nates (homology model).
bRadius of gyration.
cThe number of hydrogen bonds (intramolecular).
dSolvent-accessible surface area.
Table II
Comparison Between Secondary Structures of Cry1A(a) (PDB ID 1CIY) and the Model Generated by Homology Modeling (HM-Cry1A(b)16)
Domain I Domain II Domain III
Cry1A(a)a HM-Cry1A(b)16 Cry1A(a)a HM-Cry1A(b)16 Cry1A(a)a HM-Cry1A(b)16
a1 Pro35-Ser48 Pro7-Ser20 b1 Thr259-Val260 Arg230-Val232 b16 Ile464-Ile465 Asn436-Ile438
a2 Ala54-Il63 Gly27-Trp37 b2 Glu266-Thr269 Ile239-Thr241 b17 Ile470-Leu474 Ile443-Leu448
a3 Pro70-Ile84 Ser43-Ile56 a13 Pro271-Glu274 Pro243-Glu246 a18b Leu475-Lys477 –
a4 Glu90-Ala119 Glu62-Ala91 a14 Ala284-Gln289 Ala256-Gly261 b18 Asn480-Leu481 Asn453-Gly455
a5 Pro124-Ala144 Pro96-Phe120 b3 Asp298-His310 Ile271-His282 b19 Ser486-Val488 Ser459-Val461
a6b Pro146-Leu148 – b4 Phe313-Pro325 Glu285-Ser296 b20 Ile498-Arg501 Ile471-Arg474
a7 Gln154-Phe178 Arg126-Trp154 a15b Val326-Phe328 – b21 Gly505-Ile514 Gly478-Thr488
a8b Gln180-Trp182 – b5 Phe333-Phe334 Phe305-Phe307 b22 Tyr522-Ser530 Arg494-Thr504
a9 Ala186-Val218 Ala158-Arg189 b6b Phe338-Gly339 – b23 Leu534-Ile540 Leu507-Asp514
a10 Ser223-Thr239 Ser195-Asn221 b7 Ala345-Ser351 Tyr310-Thr312 b24 Arg543-Phe550 Arg516-Phe523
a11b Leu241-Val244 – bc – Gln320-Ala324 a19b Ser562-Ser564 –
a12b Ser248-Tyr250 – b8 Ile357-Arg367 Gly329-Arg340 b25 Arg566-Gly569 Arg539-Phe543
b9 Leu380-Phe390 Gln351-Gly363 b26 Ser580-His588 Gly552-His561
b10 Thr400-Tyr402 Ala371-Tyr373 b27 Val596-Pro605 Glu568-Ala579
b11 Val408-Asp409 Val379-Ser381
a16 Ser410-Asp412 Leu382-Glu384
a17 Pro423-Gly426 Pro394-Gly397
b12 His429-Val434 Ser399-Ser410
b13b Leu437-Ser438 -
b14b Thr446-Ala449 -
b15 Phe452-His456 Val417-Arg430
aStructures (a-helix and b-strand only) obtained from http://www.rcsb.org/pdb/explore/remediatedSequence.do?structureId5 1CIY.
bAsecondary structures that appear only in Cry1A(a),
cBsecondary structures that appear only in HM-Cry1A(b)16.
was proposed by homology modeling based on chain A
that is 590 aa long. Sequence identity of each template and
respective alignments are depicted in Supporting Informa-
tion Figure S1. Cry1A(b)16 alignment with the empirical
structures from PDB shows that domain I (residues 1 to
240) and domain 2 (residues 241 to 446) mostly contain
conserved residues, while domain III (residues 447 to 591)
shows only 33% of conserved residues (48 amino acid resi-
dues; Supporting Information Fig. S1).35,36
One hundred models were independently generated
for HM-Cry1A(b)16. Quality of the templates and of the
homology model (model chosen because of the best
DOPE score) was evaluated using software applications
PROCHECK20 and Errat21 implemented on SAVES
(Structural Analysis and Verification Server, http://nih-
server.mbi.ucla.edu/SAVES/) and Z-Score (ProSA-web
Protein Structure Analysis).22,23 The first software pack-
age examines residue-by-residue geometry and the overall
structure geometry, whereas the Z-score was used for the
refinement and validation of empirical protein structures
and for structure prediction/modeling.
Table I shows a comparison of HM-Cry1A(b)16 struc-
tural parameters with templates Cry1A(a) and Cry1A(c).
The HM-Cry1A(b)16 structure contains 93.2% of resi-
dues in the most favored regions, which is higher than
the 90% defined as a criterion for a good-quality mod-
el.20 All the remaining parameters were also in good
agreement with the ones determined for empirical con-
formations of Cry1A(a) and Cry1A(c), showing only
0.2% of residues in disallowed regions (Table I). The Z-
Figure 2
Superposition of the Ca backbone of molecules DM-Cry1A(b)16 (blue,
obtained by molecular dynamics simulations) and HM-Cry1A(b)16
(red, obtained by homology modeling). [Color figure can be viewed at
wileyonlinelibrary.com]
Figure 3
The outline of the procedures in this study and the development of sensor-based methods for detection in foods. [Color figure can be viewed at
wileyonlinelibrary.com]
score for TB-Cry1A(b)16 was 29.78, which is very simi-
lar to the Z-scores of the empirical structures of homo-
log proteins Cry1A(a) and Cry1A(c) (obtained by X-ray
diffraction; Table I). Therefore, the proposed HM-
Cry1A(b)16 can be considered a reliable 3D model of the
native toxin.22
As expected, the fold of the HM-Cry1A(b)16 model
resembles the general fold observed in Cry1A(a) and
Cry1A(c) [Fig. 1(A) and Table II]. Table II shows the
secondary structures in HM-Cry1A(b)16. Domain I (resi-
dues 1–229) consists of eight helices (a1–a5, a7, a9–
a10) in opposition to the 12 a-helices of the Cry1A(a)
secondary structure.
In domain II (residues 230–435)—which consists of
four helices (a13–a14, a16–a17) and 13 b-strands—
three b-sheets (6, 12, and 13) and a-Helix 15 from the
Cry1A(a) sequence were not identified in TB-
Cry1A(b)16. In the third domain (residues 436–590)—
which contains 12 b-strands—the a-helices (18 and 19)
were also not detected in the secondary structure of TB-
Cry1A(b)16. The region of domain III in the alignment
has a small proportion of conserved residues (Supporting
Information Fig. S1); therefore, an additional step of
model refinement was carried out using molecular
dynamics simulations.
Molecular dynamics simulations
In order to confirm stability of the target HM-
Cry1A(b)16 structure, to avoid artifacts and to increase
Figure 4
FPcH_77-91 (A, B, and C). Global structure for the last frame of molecular dynamics simulations for DM-BTCry1A(b)16. (A) DM-BTCry1A(b)16
as ribbon representation and peptide PcH_77-91 as stick representation (green). (B) Expansion of the peptide shown as a stick model (green). (C)
DM-BTCry1A(b)16 represented by the surface and peptide region (green). Pt_282-292 (D, E, and F). Global structure for the last frame of molecu-
lar dynamics simulations for DM-BTCry1A(b)16. (D) DM-BTCry1A(b)16 represented by ribbons and peptide Pt_282-292 by sticks (green); (E)
expansion of the peptide represented by sticks (green); and (F) DM-BTCry1A(b)16 represented by the surface and peptide region (green). [Color
figure can be viewed at wileyonlinelibrary.com]
the sampling, two molecular dynamics simulations with
duration of 30 ns were carried out using different start-
ing atomic velocities from a Maxwellian distribution. To
ensure that the simulations were stable, some structural
parameters such as the atom-positional root-mean-
square deviation (RMSD), the radius of gyration (Rg),
total number of intramolecular hydrogen bonds (NHb),
and the solvent-accessible surface area (SASA) were
monitored in the course of the molecular dynamics
simulations. Figure 1(B) presents two simulations in
each panel; black and red curves correspond to simula-
tions 1 [Cry1A(b)16_S1] and 2 [Cry1A(b)16_S2],
respectively. From these data, it is possible to verify that
the stability of the systems was attained during the last
5 ns of the simulation. The average values of the parame-
ters calculated for the last 5 ns during the simulations of
each system (the period defined as the production stage)
are shown in Table III. These data indicate that when each
parameter is considered independently, no significant
variations were observed among the simulations, thus
indicating conformational stability of the proposed
structure.
The system achieved an adequate amount of sampling,
and no significant structural deviations could occur after
25 ns of the simulation. Because of the lower average val-
ue of RMSD (0.276 0.01; Table III) in relation to the
structure generated by homology [HM-Cry1A(b)16], the
refined model with a lower energy obtained by simula-
tion 02 (Cry1A(b)16_S02, named DM-Cry1A(b)16) was
chosen to study the immunogenic peptides and for the
development of biosensors. As expected, the fold of the
refined DM-Cry1A(b)16 model resembles the general
fold observed in HM-Cry1A(b)16 (Fig. 2).
Prediction of peptides as molecular markers
for detection of GMO
The protein sequence corresponding to Cry1A(b)16
was retrieved from the NCBI database (accession No.
AAK55546). Cry1A(b)16 is a d-endotoxin produced by
B. thuringiensis AC11 (H14). The entire primary
sequence of this protein is composed of 1155 aa (Sup-
porting Information Fig. S1). The ExPASy PeptideCutter
tool was used to subject Cry1A(b)16 to in silico cleavage
site prediction using trypsin and chymotrypsin for high
(HS) and low (LS) specificity.31 (Fig. 3)
A cleavage site map and the table of cleavage site posi-
tions were analyzed, and peptides 10 and 30 aa length
were selected for compositional analysis. The two selected
peptides after theoretical digestion were chosen after in
silico analysis of the antibody production capacity, such
as structure determination of epitopes and T-cell epitope
prediction.31
The nomenclature of the peptides takes into account
positioning characteristics of the sequence in the native
protein and how the peptide was generated: for example,
PcH_77-91 (P5 peptide; cH5 chymotrypsin with high
specificity; positions 77–91 in the native protein) and
Pt_282-292 (P5 peptide; t5 trypsin; positions 282–292
in the native protein), these peptides are indicated in the
native protein structure in Figure 4.
In some situations, we could use the nomenclature
PcH_77-91 C (C5 cysteine residue at the C terminal),
because the peptides were synthesized with a C-terminal
cysteine to enable conjugation to KLH for polyclonal-
antibody production.
Peptides PcH_77-91 and Pt_282-292 were selected,
synthesized, and purified by RP-HPLC, and the resulting
peptides showed estimated purity >98% [Figure 5(A)].
After synthesis, they were designated as PcH_77-91 C
and Pt_282-292 C.
Molecular masses were determined and confirmed for pure
peptides by MALDI-TOF MS, with [M1H]15 1976.30 Da
for PcH77-91 and [M1H]15 1178.36 Da for Pt282-292.
The de novo sequencing by MS/MS was performed to confirm
the primary sequence (Supporting Information Figs. S2
and S3).
After in-house assessment of the potential peptides for
antibody production, bioinformatics analyses of the
Figure 5
(A) Representative chromatograms of purified synthetic peptides
PcH_77-91 and Pt_282-292. The experiments were conducted indepen-
dently and are grouped in the figure for comparison purposes. The
numbers above the fractions correspond to the retention time (Tr). The
fractions were collected manually, and the curves correspond to moni-
toring at 216 nm; mAU: arbitrary units. (B) An immunoblot of poly-
clonal anti-PcH_77-91 (Lane 1) and anti-Pt_282-292 antibodies (Lane
2) as the primary antibody. Antigens were analyzed by SDS-PAGE and
blotted onto a nitrocellulose membrane. [Color figure can be viewed at
wileyonlinelibrary.com]
peptides were also carried out by a specialized company
(GenScript, NJ, USA) that produced the antibodies.
PcH_77-91 and Pt_282-292 [Fig. 5(A)] were also sug-
gested by GenScript as good candidates for animal
immunization, and these two peptides were selected for
antibody production. Immunoblots [Fig. 5(B)] illustrate
the successful development of anti-PcH_77-91 and anti-
Pt_282-292 polyclonal antibodies against the respective
target peptides. Specific binding was observed for each
peptide, pointing to good quality of the antibodies.
CONCLUSION
In this work, a novel homology modeling and struc-
tural analysis of 3D models obtained from Cry1A(b)16
(Bacillus thuringiensis) were performed. Molecular
dynamics simulations were carried out to refine the cho-
sen model, and using the obtained data, we analyzed its
global structure. The new DM-BTCry1A(b)16 model can
be used in research on new biosensors.
In general, two peptides, namely, PcH_77-91 and
Pt_282-292, were identified as the best candidates for
antibody production and were successfully used as
immunogens, resulting in successful production of the
respective reactive polyclonal antibodies. To the best of
our knowledge, this is the first attempt to select and
define potential linear epitopes for immunization of ani-
mals and subsequently to generate adequate antibodies
for Cry1A(b)16 recognition. The next steps will include
the development of an protein-based sensor for
Cry1A(b)16 detection as a marker of GM maize in food.
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